Ken Griffin
CELU icon

Ken Griffin’s Celularity CELU Stock Holding History

Ken Griffin’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25,200
Closed -$52.2K – 12772
2025
Q3 		$52.2K Buy
+25,200
New +$70.5K ﹤0.01% 12181
2025
Q2 		– Sell
-100
Closed -$173 – 12744
2025
Q1 		$173 Sell
100
-14,700
-99% -$27.8K ﹤0.01% 14313
2024
Q4 		$30.8K Sell
14,800
-3,000
-17% -$7.16K ﹤0.01% 12854
2024
Q3 		$52.9K Buy
17,800
+3,500
+24% +$10.3K ﹤0.01% 11842
2024
Q2 		$44.8K Buy
14,300
+5,800
+68% +$20.1K ﹤0.01% 11890
2024
Q1 		$44.5K Buy
8,500
+7,650
+900% +$31.5K ﹤0.01% 12289
2023
Q4 		$2.1K Hold
850
– – ﹤0.01% 13740
2023
Q3 		$1.89K Hold
850
– – ﹤0.01% 13790
2023
Q2 		$4.53K Hold
850
– – ﹤0.01% 13589
2023
Q1 		$5.27K Sell
850
-50
-6% -$402 ﹤0.01% 13883
2022
Q4 		$11.6K Sell
900
-480
-35% -$8.85K ﹤0.01% 13560
2022
Q3 		$32K Sell
1,380
-610
-31% -$18.5K ﹤0.01% 11865
2022
Q2 		$68K Sell
1,990
-3,270
-62% -$266K ﹤0.01% 11728
2022
Q1 		$458K Sell
5,260
-11,040
-68% -$662K ﹤0.01% 9600
2021
Q4 		$835K Sell
16,300
-4,860
-23% -$311K ﹤0.01% 8382
2021
Q3 		$1.5M Buy
21,160
+11,660
+123% +$941K ﹤0.01% 7081
2021
Q2 		$967K Sell
9,500
-3,120
-25% -$316K ﹤0.01% 8454
2021
Q1 		$1.27M Buy
+12,620
New +$1.29M ﹤0.01% 7504

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $9.42B AUM 17.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

Ken Griffin's CELU Position: Q1 2026 in Review

Ken Griffin sold out of Celularity (CELU) in Q1 2026, closing a stake of 77,657 shares — an estimated $86.2K sold.

Ken Griffin first reported a position in CELU in Q1 2021 and held it in 12 quarters. The position peaked at $3.16M in Q1 2021. 38 funds tracked by Wall St. Rank hold CELU as of Q1 2026.

  • Ken Griffin reported no remaining Celularity position as of Q1 2026 after selling out during the quarter.
  • Ken Griffin sold 77,657 Celularity shares in Q1 2026, an estimated $86.2K.
  • Ken Griffin first reported a position in Celularity in Q1 2021 and held it in 12 quarters.
  • Ken Griffin's Celularity position peaked at $3.16M in Q1 2021.
  • 38 funds tracked by Wall St. Rank held Celularity as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.